Skip to main content

Table 1 Table 1

From: An audit to assess the impact of introducing a protocol of bilateral whole breast and axillary ultrasound for assessment of screen-detected cancers

  Audit (n = 1,700) Control (n = 105)
Additional biopsy 318 (19%) 6 (5.7%)
Additional biopsy shows cancer 160 (9.4%) 6 (5.7%)
Contralateral biopsies 47 (2.8%) 0 (0%)
Bilateral cancer 22 (1.3%) 0 (0%)
FNAC of axillary node 150 (8.8%) 0 (0%)
FNAC shows nodal metastases 55 (3.2%) 0 (0%)